Food & Beverages Global On demand · 24-48h

Global Deep-processed Bovine Blood Products Market Strategic Research Report

Global Deep-processed Bovine Blood Products Market Strategic…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Deep-processed Bovine Blood Products Market
$5872025
5.2%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Plasma Protein Powder, Hemoglobin Powder, Heme, Others

By Application: Drug Ingredients, Cosmetic Ingredients, Feed Additives, Pesticide Ingredients, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: APC, VEOS Group, PRODUCTOS PILAR SA, Nutraprot S.A., JBS S.A., Yeruva S.A., Lican Food, Hemoprot, ArgenProt, Logros S.A.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 90 pages
Market size 2025
$587
Million USD
Forecast CAGR
5.2%
2025-2032
Forecast 2032
$837
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global Deep-processed Bovine Blood Products market size is predicted to grow from US$ 587 million in 2025 to US$ 837 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.

In 2025, the production of deep-processed bovine blood products reached 30,000 tons, with an average price of US$20,000 per ton..

Bovine heme is not ordinary protein powder, but rather the iron-containing active structure within hemoglobin. Hemoglobin itself is an iron-containing protein in red blood cells, responsible for oxygen transport; the "heme" in heme is an iron-containing porphyrin group bound to globin. Medical and biochemical literature also defines hemoglobin as a protein present in red blood cells, responsible for oxygen transport.

After cattle slaughter blood is collected through anticoagulation and centrifugation, the supernatant is plasma. This plasma is then sterilized, concentrated, and spray-dried to form bovine plasma protein powder.

Bovine hemoglobin powder comes from the red blood cell fraction after blood separation and can also be called bovine hemoglobin powder, spray-dried bovine hemoglobin powder, or spray-dried bovine erythrocyte powder. Whole blood, after centrifugation, is typically separated into two main components: plasma and red blood cells. The red blood cell fraction is then spray-dried to obtain hemoglobin powder.

Global key Deep-processed Bovine Blood Products players cover APC, VEOS Group, PRODUCTOS PILAR SA, Nutraprot S.A., JBS S.A., etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Deep-processed Bovine Blood Products market?

What factors are driving Deep-processed Bovine Blood Products market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Deep-processed Bovine Blood Products market opportunities vary by end market size?

How does Deep-processed Bovine Blood Products break out by Type, by Application?

This report presents a comprehensive overview of the global Deep-processed Bovine Blood Products market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Plasma Protein Powder
  • Hemoglobin Powder
  • Heme
  • Others

Segment by Dry Form

  • Spray-dried Type
  • Freeze-dried Type

Segment by Application

  • Drug Ingredients
  • Cosmetic Ingredients
  • Feed Additives
  • Pesticide Ingredients
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Deep-processed Bovine Blood Products market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Drug Ingredients, Cosmetic Ingredients, Feed Additives evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Deep-processed Bovine Blood Products Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.2%
Regional growth momentum
Market share by segment
Key metrics
Base value
$587
2025
Forecast
$837
2032
CAGR
5.2%
2025–2032
영역들
5
global
Key companies
APCVEOS GroupPRODUCTOS PILAR SANutraprot S.A.JBS S.A.Yeruva S.A.Lican FoodHemoprot
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Plasma Protein PowderHemoglobin PowderHemeOthers
By Application
Drug IngredientsCosmetic IngredientsFeed AdditivesPesticide IngredientsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Plasma Protein Powder
  • 3.1.3 Hemoglobin Powder
  • 3.1.4 Heme
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Drug Ingredients
  • 4.1.3 Cosmetic Ingredients
  • 4.1.4 Feed Additives
  • 4.1.5 Pesticide Ingredients
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 APC
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 VEOS Group
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 PRODUCTOS PILAR SA
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Nutraprot S.A.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 JBS S.A.
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Yeruva S.A.
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Lican Food
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Hemoprot
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 ArgenProt
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Logros S.A.
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Deep-processed Bovine Blood Products market?
The global Deep-processed Bovine Blood Products market is estimated at US$ 587 million in 2025 (base year) and is projected to reach US$ 837 million by 2032.
What is the forecast CAGR for the Deep-processed Bovine Blood Products market?
The market is expected to grow at a CAGR of 5.2% from 2026 to 2032, expanding from US$ 587 million in 2025 to US$ 837 million in 2032, roughly 1.4 times its base-year value.
What is Deep-processed Bovine Blood Products?
In 2025, the production of deep-processed bovine blood products reached 30,000 tons, with an average price of US$20,000 per ton..
What are the main segments of the Deep-processed Bovine Blood Products market by type?
By type, the market is segmented into Plasma Protein Powder, Hemoglobin Powder, Heme and Others.
Which applications drive demand in the Deep-processed Bovine Blood Products market?
Key applications covered include Drug Ingredients, Cosmetic Ingredients, Feed Additives, Pesticide Ingredients and Others.
Who are the key players in the Deep-processed Bovine Blood Products market?
Key players profiled include APC, VEOS Group, PRODUCTOS PILAR SA, Nutraprot S.A., JBS S.A., Yeruva S.A., Lican Food and Hemoprot, among 10 companies covered in total.
Which regions and countries are covered for Deep-processed Bovine Blood Products?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Deep-processed Bovine Blood Products market?
What factors are driving Deep-processed Bovine Blood Products market growth, globally and by region?
Who should buy the Deep-processed Bovine Blood Products market report?
The report is intended for manufacturers and solution providers, distributors and end users in Drug Ingredients, Cosmetic Ingredients and Feed Additives, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Deep-processed Bovine Blood Products market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.